Global Cardiology Summit

Marco Mazzanti is a Cardiologist currently working as Honorary Consultant at Barts Heart Centre in London, UK. He holds a fellowship at European Society of Cardiology since 2004. Since January 2012 till 2013 Position of Project Leader of Artificial Intelligence in Medicine Project at at Lancisi Heart Hospital, Ancona, Italy , focusing on innovative models for early risk stratification in acute chest pain evaluation (Acute Coronary Syndrome setting). Marco has more than 10 years of experience on Artificial Intelligence (AI) in Cardiology and more than 25 years in clinical practice. He has also been involved in outbreak investigations of AI in cardiology being currently the Director of Multicenter Research Framework on AI in cardiology like the ARTICA Registry about evaluation of stable chest pain by AI CDSS. He has presented and published abstracts and papers on the specific topic of AI in cardiology.

Dr Marouli’s research interests lie at the interface of genetics, bioinformatics and statistics, in order to achieve a better understanding of human biology and disease prediction with the use of “Big Data”. Her work focuses on using human genetics to identify genes that influence common diseases and quantitative traits, including height and adiposity. Dr Marouli implements novel computational methods, including machine learning, to gain biological insights from human genetic and phenotypic data. She has a leading role in the large international consortium (GIANT) that has discovered almost all of the genetic variants that are known to influence human height and obesity related traits. Dr Marouli has also leading work and contributions in global consortia (GLGC, CHARGE CARDIoGRAMplusC4D) for complex traits and diseases.In addition to gene discovery efforts, Dr Marouli is also interested in genetic-epigenetic approaches to complex phenotypes. Dr Marouli is focusing on the genetics of thyroid disease. Her recent work integrates the use of genetic data and a battery of state of the art approaches, for causal inference and mendelian randomisation, to elucidate the genetic interplay between risk factors and disease.

Ruwanka Uhanowita Marage is a 5th year medical student from the University of Liverpool. She has carried out various research projects and is interested in a future career in vascular surgery. She has presented her work at both a regional and national level and is the Vice-Chair for an upcoming conference she has helped to organise. She has previously been Vice-President of the Liverpool Cardiovascular and Thoracic Society, Treasurer to Liverpool OSCE society and Charity Representative to Liverpool Dermatological Society. She shows a great commitment to teaching, having carried out several lectures and been part of a peer-mentoring programme. As well as that, she has acted as an examiner for a series of mock OSCEs. She is an enthusiastic pianist who enjoys baking in her free time.

Evgeny Gennadievich Zhelyakov is a doctor by profession and works for Moscow State University Arrhythmology Department. The area of his interest is atrial fibrillation, heart failure, interventional electrophysiology. Evgeny has 20 years of doctors and scientific practice. He also took a part in CABANA trial within 5 years.

Dr.Saurabh Potdar is an interventional cardiologist by profession and works with SYMBIOSIS MEDICAL COLEGE FOR WOMEN,Pune. He holds a DM in Cardiology and MD in Internal Medicine. He gathers a total experience of 3 years in the field of Interventional cardiology. Dr. Saurabh is passionate about working in preventive cardiology as well as in advanced imaging modalities in the field of Structural heart disease and Interventional Cardiology.

Dr Ajit Jadhav is an interventional cardiologist by profession and works with Dr D Y Patil Medical College, Pune. He holds a DNB in Cardiology and MD in Internal Medicine. He gathers a total experience of 3 years in the field of Interventional cardiology. Dr. Ajit is passionate about working in preventive cardiology as well as in advanced imaging modalities in the field of Structural heart disease and Interventional Cardiology.

Muluken Altaye Ayza is a clinical pharmacist by profession and works as a lecturer and researcher at Mekelle University, Ethiopia. He holds an MSc in clinical pharmacy. He has 3 years of teaching experience in public university. Muluken is very interested in cardio-oncology researches.

Dr. Mohammad Shoaib Hamrah graduated from Kabul Medical University in 1991.He successfully completed his master’s and PhD degree at Nagoya University Graduate School of Medicine, Nagoya, Japan. He is a recipient of awards, scholarships and fellowships from the World Health Organization, the Japanese government, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Takeda Science Foundation. He also worked as a postdoctoral researcher in the Department of Cardiology, Nagoya University Graduate School of Medicine. He has attended several international academic conferences.

47 years of involvement in Cardiovascular and Thoracic Surgery in various capacities as Assistant Professor,Professor and Head of the Department ,Government General Hospital and Institute of Child Health and Hospital for Children, Madras Medical College. Performed around 11, 000 surgeries with 7000 surgeries performed on newborns, infants and children less than 12 years. Involved in various research activities and publication of papers in National and International Journals. Served as examiner for MCh (CTS) in different Universities. At present involved in a project Solution for Cardiac Afflicted Needy (SOCAN) which involves Free Cardiac Surgery & follow-up for the under-privileged.

Fabiana Tortora is a PhD student at the University of Campania "Luigi Vanvitelli" of Naples, who will be awarded the PhD title in "Biochemical and Biotechnological Sciences" this December 2019. During the 3 years of her PhD she repeatedly exposed in individual way with seminars addressed to the College and to other teachers the results on the progress of the thesis work. Furthermore, these three years of doctoral studies have been enriched, also by research activities abroad, by publications and participations in conferences. In particular, during the second year for a period of 3 months, part of the research activity was carried out in Germany at the “Medizinische Fakultät, Physiologisches Institut I, Wilhelmstrasse 56 D-72076 Tübingen”, under the guidance of Prof. Dr. med. Dr. h.c. Florian Lang. The work focused on a greater understanding of eriptosis, a programmed death process that red blood cells encounter, with the aim of improving the side effects of anemia caused by chemotherapy drugs in cancer patients. Moreover, Fabiana holds a Second Level Degree in Biology specializing in Nutrition with 110 cum laude and a First Level Degree in Biological Science specializing in Pathophysiology at the Federico II University of Naples.

Xiangjun Fu：Female, master, research direction is environmental toxicology.

Erno Remsey-Semmelweis is a Cardio-thoracic & Vascular & General Surgeon at The University Clinics of Giessen & Marburg Gmbh, Head of Interventional Clinical Aorta & Aortic Valve Program and Director of Experimental Translational Hybrid-Or Laboratory UniversityClinics of Giessen & Marburg Gmbh. He was appointed in Aortic-Vascular Surgery Program-Team at Royal Brompton and HarefieldHospitals NHS Foundation Trust, London, UK.Erno Remsey-Semmelweis is a Cardio-thoracic & Vascular & General Surgeon at The University Clinics of Giessen & Marburg Gmbh,Head of Interventional Clinical Aorta & Aortic Valve Program and Director of Experimental Translational Hybrid-Or Laboratory UniversityClinics of Giessen & Marburg Gmbh. He was appointed in Aortic-Vascular Surgery Program-Team at Royal Brompton and Harefield Hospitals NHS Foundation Trust, London, UK.